Liquisolid technique to enhance and to sustain griseofulvin dissolution: Effect of choice of non-volatile liquid vehicles

International Journal of Pharmaceutics

Volumn 434, Issue 1-2, 2012, Pages 122-132

  Elkordy, Amal Ali ^a   Essa, Ebtessam Ahmed ^b,c   Dhuppad, Shreyas ^a   Jammigumpula, Poojitha ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b Tanta University   (Egypt)

^c UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

Capryol 90; Cremophor EL; Griseofulvin; Kollicoat SR 30 D; Liquisolid formulations; Synperonic PE L61

Indexed keywords

DRUG CARRIER; GRISEOFULVIN; SURFACTANT;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; FLOW; HYDROPHILICITY; INFRARED SPECTROSCOPY; LIQUID; LIQUISOLID POWDER SYSTEM; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROCESS TECHNOLOGY; SUSTAINED DRUG RELEASE; TABLET;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; GRISEOFULVIN; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, THEORETICAL; PHARMACEUTICAL VEHICLES; SOLUBILITY; SURFACE-ACTIVE AGENTS; TABLETS; TIME FACTORS;

EID: 84864150278     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.05.072     Document Type: Article

References (37)

1. B. Akinlade, A.A. Elkordy, E.A. Essa, and S. Elhagar Liquisolid systems to improve the dissolution of furosemide Sci. Pharm. 78 2010 325 344
2. G.S. Banker Tablets L. Lachman, H.A. Liberman 3rd The Theory and Practice of Industrial Pharmacy 1987 Varghese Publishing House Bombay, India 293 345
3. British Pharmacopoeia, 2011.
4. Benoit, J.P., Lanprecht, L., 2004. Use of p-glycoprotein inhibitor surfactant at the surface of a colloidal carrier. Patent W02004071498.
5. R.L. Carr Evaluation of flow properties of solids Chem. Eng. 72 1965 163 168
6. A.A. Elkordy, A. Jatto, and E.A. Essa In situ controlled crystallization as a tool to improve the dissolution of glibenclamide Int. J. Pharm. 428 2012 118 120
7. R.H. Fahmy, and M.A. Kassem Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. 69 2008 993 1003
8. I.D. Gonjari, A.B. Karmarkar, and A.H. Hosmani Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets Dig. J. Nanomater. Biostruct. 4 2009 651 661
9. C.M. Hentzschel, M. Alnaief, I. Smirnova, A. Sakmann, and C.S. Leopold Enhancement of griseofulvin release from liquisolid compacts Eur. J. Pharm. Biopharm. 80 2012 130 135
10. T. Higuchi Mechanism of sustained-action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
11. A.W. Hixson, and L.J.H. Crowel Dependence of reaction velocity upon surface and agitation (I) theoretical consideration Ind. Eng. Chem. 23 1931 923 931
12. D.J. Jarmer, C.S. Lengsfeld, K.S. Anseth, and T.W. Randolph Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor J. Pharm. Sci. 94 2005 2688 2702
13. Y. Javadzadeh, M.R. Siahi-Shadbad, M. Barzegar-Jalali, and A. Nokhodchi Enhancement of dissolution rate of piroxicam using liquisolid compacts Farmaco 60 2005 361 365
14. Y. Javadzadeh, B. Jafari-Navimipour, and A. Nokhodchi Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine) Int. J. Pharm. 341 2007 26 34
15. Y. Javadzadeh, M.R. Siahi, S. Asnaashari, and A. Nokhodchi An investigation of physicochemical properties of piroxicam liquisolid compacts Pharm. Dev. Technol. 12 2007 337 343
16. Y. Javadzadeh, L. Musaalrezaei, and A. Nokhodchi Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices Int. J. Pharm. 362 2008 102 108
17. Y. Javadzadeh, H. Shariati, E. Movahhed-Danesh, and A. Nokhodchi Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts Drug Dev. Ind. Pharm. 35 2009 243 251
18. K.A. Khan The concept of dissolution efficiency J. Pharm. Pharmacol. 28 1975 48 49
19. A.S. Kulkarni, N.H. Aloorkar, M.S. Mane, and J.B. Gaja Liquisolid systems: a review Int. J. Pharm. Sci. Nanotech. 3 2010 795 802
20. A. Nokhodchi, Y. Javadzadeh, M.R. Siahi-Shadbad, and M. Barzegar-Jalali The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts J. Pharm. Pharm. Sci. 8 2005 18 25
21. A. Nokhodchi, Y. Javadzadeh, and L. Mosaalrezaei Liquisolid technique for sustaining the drug release from compacts J. Pharm. Pharmacol. 59 2007 A19 A20
22. A. Nokhodchi, R. Aliakbar, S. Desai, and Y. Javadzadeh Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release Colloids Surf. B 79 2010 262 269
23. B.D. Rege, J.P. Kao, and J.E. Polli Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 2002 237 246
24. R.F. Shangraw Compressed tablets by direct compression H.A. Liberman, L. Lachman, J.B. Schwartz 2nd Pharmaceutical Dosage Forms: Tablets 1989 Marcel Dekker New York 195 220
25. A. Sheth, and C.I. Jarowski Use of powdered solutions to improve the dissolution rate of polythiazide tablets Drug Dev. Ind. Pharm. 16 1990 769 777
26. R.M. Silverstein, G.C. Bassler, and T.C. Morril Spectrometric Identification of Organic Compounds 1991 Wiley New York pp. 91-131
27. S. Spireas, C.I. Jarowski, and B. Rohera Powdered solution technology: principles and mechanism Pharm. Res. 9 1992 1351 1358
28. S. Spireas, and S. Sadu Enhancement of prednisolone dissolution properties using liquisolid compacts Int. J. Pharm. 166 1998 177 188
29. S. Spireas, S. Sadu, and R. Grover In vitro release evaluation of hydrocortisone liquisolid tablets J. Pharm. Sci. 87 1998 867 872
30. Spireas, S., Bolton, S.M., 1999. Liquisolid systems and methods of preparing same. U.S. Patent 5, 968,550.
31. S. Spireas, T. Wang, and R. Grover Effect of powder substrate on the dissolution properties of methylchlorothiazide liquisolid compacts Drug Dev. Ind. Pharm. 25 1999 163 168
32. P. Srirangam, and S.J. Vidya Modulation of the p-glycoproein-mediated intestinal secretion of glibenclamide: in vitro and in vivo assessments J. Young Pharm. 2 2010 379 383
33. S. Sultana, I. Ahmed, R.I. Muhammad, and M.d.H. Rahman Development of salbutamol sulphate sustained release pellets using acrylic polymer and polyvinyl acetate polymer and evaluation of in vitro release kinetics Dhaka Univ. J. Pharm. Sci. 9 2010 109 118
34. N. Tiong, and A.A. Elkordy Effect of liquisolid formulations on dissolution of naproxen Eur. J. Pharm. Biopharm. 73 2009 373 384
35. E.R. Townley Griseofulvin K. Florey, Analytical Profiles of Drug Substances 1979 Academic Press San Diego 229 231
36. V.B. Yadav, and A.V. Yadav Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique J. Pharm. Sci. Res. 1 2009 44 51
37. J. Zezhi, Z.J. Shao, L. Morales, S. Diaz, and N.A. Muhammad Drug release from Kollicoat SR 30D-coated nonpareil beads: evaluation of coating level, plasticizer type, and curing condition AAPS PharmSciTech 3 2002 1 7